• "Enter your caption here"
  • "Enter your caption here"
  • "Enter your caption here"


Berlin Brandenburg, GMBH building
Amhochwald 30, 14532 Kleinmachnow

Office hours
10:00 to 4:00
Monday to Friday


Journal Detail

Journal Name
ISSN (P) 2640-9275
ISSN (O) 2640-9275
Country USA
Frequency Bi-Monthly
Journal Discipline
Area of specialization
Journal Language
Year of First Publication 2017
Web Site crimsonpublishers.com
Editor Mario Ciampolini
Email abb@crimsonpublishers.com
Phone No. +1(929)600-8049
Cosmos Impact Factor 2018 : 3.658
Journal Description

Advancements in Bioequivalence & Bioavailability (ABB) is a online open access journal that mainly concentrates on publication of original research on bioequivalence and bioavailability, pharmacogenomics, pharmacodynamic and pharmacokinetic studies and its variations, drug efficacy, pharmacotherapeutics. The journal mainly focuses on the integration of new developments in the genome project and proteomics in clinical medicine, pharmacology and therapeutics, proteomics, new techniques that invented to study drug efficacy, stability and its applications, properties and functioning of drugs, dissolution rate, disintegration studies, genetic variability on drug toxicity and efficacy. It aims to publish highly effective papers related to all areas that come under bioequivalence and bioavailability. The journal has a proficiently supported and prominent editorial board. ABB offers a promising platform for researchers to publish their research papers and explore their inventions and knowledge. ABB publishes all types of articles like research, reviews, case reports, mini reviews, short communication, opinion, book reviews etc.